Trial Profile
A randomised double blind placebo controlled pilot trial of oxytocin efficacy in treating detoxified opioid dependent individuals
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Opioid-related disorders; Substance withdrawal syndrome
- Focus Therapeutic Use
- 02 Jul 2019 Status changed from recruiting to discontinued.
- 12 Nov 2014 New trial record